Company enters obstructive sleep apnea space, enhancing its portfolio of Neuromodulation treatments and therapies.
LivaNova receives FDA approvals for SenTiva device and VNS Therapy Programming System for epilepsy treatment.
CELEBRATING 10 YEARS OF CLINICAL USE A renowned cardiac surgeon, Prof. Bart Meuris, talks about his experience and the results that have been achieved in the last ten years thanks to Perceval.
Enters Transcatheter Mitral Valve Replacement (TMVR) space with unique design for its investigational device.
LivaNova celebrates 100,000 patients enjoying more seizure-free moments with VNS Therapy.
LivaNova receives regulatory approval in Canada for its innovative Memo 3D ReChord annuloplasty ring for mitral valve repair
Your Browser doesn't suport iframe
Our people, our purpose, and our solutions are transforming health and changing lives, worldwide.
Powered by Tamtamy
LivaNova PLC - Registered in England and Wales - Registered No. 09451374 - 20 Eastbourne Terrace, London, W2 6LG, United Kingdom